Diabetes Pro Quarterly - Fall 2017 - 9

PROFESSIONAL NEWS

Investable Opportunities continued from page 8
Well, diagnostics work only if they do not change your daily work flow. For example,
say you're brushing your teeth, and some blood enzymes that are also available in saliva
could be monitored and tested, and the results could be uploaded onto a machine. That
would be no disruption to your daily work flow. Billions of people in the world brush
their teeth. You could utilize that. However, if you're asked to do something outside of
your normal routine, many patients will do it for some time and then stop.
How do you cause behavior change? One aspect that has worked invariably in all
behavior-change programs is to enroll somebody other than the one whose behavior
needs to be changed. A great non-health care example comes from a 40-year-old
micro-credit lending program in Bangladesh. Investors required whoever asked for a
loan to bring five people from their village who were willing to vouch for them. If you
could do that, you could have the loan. And, of course, if you didn't pay it back, then
those five people were on the hook as well, and they wouldn't be able to get loans. This
worked very well. So in the quest to change health care behavior, the question is, can you
enroll the family? Can you enroll the friends? Can you enroll other people in the ecosystem? Noninvasive, continuous monitoring diagnostic devices are a great tool for that.

The Role of the Association in the Future of Diabetes
Ajit Singh:

One thing the Association in particular could do is to help create awareness of what is
going on outside the United States. Take a global view. China has 110 million people
with diabetes, India has 69 million, the United States has 29 million, Brazil has 14
million. And while the United States has been the center of innovation for a long time,
there's a lot of bottom-up innovation taking place elsewhere, and too often, we are simply oblivious to it. For instance, the Imperial College London teamed up with the Max
Healthcare Institute in New Delhi to study people with diabetes in India. They're tracking 10,000 peoples' diabetes using next-generation sequencing as the starting point, and
then longitudinal diagnostic data, therapeutic data, and behavior change. There is also
phenomenal diabetes technology available in Israel. Diabetes is a worldwide health issue.
Wende Hutton, a general partner at Canaan Partners:

Payment, payment, payment, payment. We have the most
expensive disease state that's rumbling through our health care
system right now. And all our payment systems actually reward
for complications down the road. The biggest impediments to
change are the reimbursement models. The Association can help
lead the discussion about where value-based reimbursement
comes from and about how we provide patients with access to all these tools that are
sitting here today outside of the classic fee-for-service system. I think that's an incredible
policy opportunity for the Association.
Ruchita Sinha:

What I'll add to what Wende said is a focus on payments for simple things-nutrition,
exercise. If we develop better payment mechanisms for simple things like that, then these
solutions will have viable business models.
We also need a community approach. Diabetes is very much a lifestyle problem, and
diabetes is a really massive cost burden on health care. So we need to think how we
tackle this as a community-employers, payers, providers, and patients alike. How
can each stakeholder pitch in to help this community be healthy?
_________________________________________________________________
Visit adainnovation.org for more articles and insights on the challenge of behavior
change, first-person perspectives, and what innovators are doing today to lead
effective solutions that transform the lives of people living with diabetes.

2017 National DSMES
Standards Now Included in
the Education Recognition
Program's DSMES
Symposium
The American Diabetes Association
Education Recognition Program (ERP)'s
Diabetes Self-Management Education
and Support (DSMES) Symposium has
been revised to include the 2017 National
Standards for DSMES and the revised
review criteria and indicators. Symposium
attendees will earn 7.25 CEUs while participating in multiple activities designed for
adult learners. The symposium promotes
networking and best practice sharing while
participants gain a thorough understanding of how to operationalize the 2017
DSMES standards. Recognized programs
will be required to have the 2017 DSMES
standards operationalized by May 1, 2018.
The ERP will conduct two more
symposiums in 2017:
*

Dallas, TX, on November 10, 2017

Philadelphia, PA, on November 17,
2017

Registration is now open at professional.
diabetes.org/erp-dsmes-recognitionsymposiums.
For more information please email
ERP@diabetes.org.

Diabetes Prevention
Program Charting Platform
Now Available
The American Diabetes Association
Education Recognition Program (ERP)
team is excited to announce that its
Diabetes Prevention Program (DPP)
charting platform is now live. Recognized
programs and DPP program coordinators
interested in using the platform should
submit a DPP Platform Interest Form or
call 1-888-232-0822 ext. 3 for information.
Please view the DPP platform flyer at
professional.diabetes.org/erpdpp for more
information and pricing. Visit diabetes.
org/erpqa to view a schedule of and
register for upcoming question-andanswer calls about the DPP platform.
DIABETESPRO QUARTERLY

http://professional.diabetes.org/erp-dsmes-recognitionsymposiums http://professional.diabetes.org/erp-dsmes-recognitionsymposiums http://professional.diabetes.org/erp-dsmes-recognitionsymposiums http://www.adainnovation.org http://professional.diabetes.org/erpdpp http://diabetes.org/erpqa http://diabetes.org/erpqa

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Fall 2017